Raiffeisen Bank International AG boosted its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 906.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,896 shares of the company’s stock after acquiring an additional 6,211 shares during the period. Raiffeisen Bank International AG’s holdings in Clorox were worth $848,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Clorox by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock worth $1,902,569,000 after purchasing an additional 272,420 shares in the last quarter. Invesco Ltd. grew its holdings in Clorox by 138.3% during the 2nd quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock valued at $389,648,000 after buying an additional 1,883,465 shares during the last quarter. Norges Bank acquired a new stake in Clorox during the 2nd quarter valued at $190,429,000. ProShare Advisors LLC increased its position in Clorox by 11.7% during the third quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock worth $159,922,000 after buying an additional 136,135 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock worth $149,983,000 after acquiring an additional 856,873 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts recently commented on CLX shares. Royal Bank Of Canada set a $132.00 price objective on Clorox in a research report on Wednesday, February 4th. Wells Fargo & Company set a $125.00 price target on shares of Clorox in a research note on Tuesday, February 17th. Evercore cut their price objective on shares of Clorox from $132.00 to $115.00 and set an “underperform” rating for the company in a research report on Wednesday, February 4th. Weiss Ratings downgraded shares of Clorox from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, February 4th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $118.73.
Clorox Stock Performance
Shares of CLX stock opened at $123.51 on Monday. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. The firm has a market capitalization of $14.93 billion, a price-to-earnings ratio of 20.18, a price-to-earnings-growth ratio of 0.61 and a beta of 0.59. The Clorox Company has a one year low of $96.66 and a one year high of $159.04. The company has a 50 day moving average price of $109.75 and a 200 day moving average price of $113.51.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. During the same quarter last year, the business earned $1.55 EPS. Sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.
Key Clorox News
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Zacks raised its FY2028 EPS view to $7.23 and upgraded select quarterly/annual estimates (including Q1 2028 to $1.37 and Q4 2026/2027 increases), signaling modestly better forward earnings visibility that can support the stock.
- Positive Sentiment: Clorox published a consumer research report “Home Care Redefined” that underscores evolving demand for wellness- and convenience-oriented home-care products — a strategic tailwind for branded consumer staples. Home Care Redefined
- Neutral Sentiment: Management presented at the Consumer Analyst Group of New York (CAGNY) conference; slides and prepared remarks provide more detail on strategy, cost actions and growth initiatives — useful for longer-term positioning but not an immediate earnings surprise. CAGNY Slides Transcript
- Negative Sentiment: Zacks trimmed multiple near-term quarterly EPS forecasts (several Q2–Q3 2026/2027 cuts and FY2027 lowered to $6.74), reflecting caution about near-term volume/mix or cost pressure — a potential headwind for sentiment and short-term guidance expectations.
- Negative Sentiment: Wells Fargo issued a “Hold” on CLX (reported as “receives a Hold”), which keeps sell-side sentiment neutral-to-cautious and may limit near-term upside from upgrades. Wells Fargo Hold
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Further Reading
- Five stocks we like better than Clorox
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
